Predicting outcomes in acute-on-chronic liver failure
Part of Digestive system clinical trials.
This study looks at new scoring systems to predict how patients with acute-on-chronic liver failure (a sudden worsening of long-term liver disease) will do. It may help doctors better understand and treat this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have acute-on-chronic liver failure, as diagnosed by your doctor.
- You must be admitted to the intensive care unit (ICU) at Al-Rajhi University Hospital.
- You cannot have liver cancer or other advanced cancers.
- You cannot be pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is comparing new scoring systems to better predict outcomes for people hospitalized with serious liver cirrhosis complications. It may help doctors understand which patients need more intensive care.
This study looks at whether different scoring tools can better predict outcomes for people with cirrhosis who are waiting for a liver transplant. It may help improve how transplant urgency is decided.
This study looks at your liver health before and after surgery to predict the risk of “acute-on-chronic liver failure,” which means a sudden worsening of liver function on top of an existing liver condition. If you qualify, your doctors may use study data to better identify who needs closer monitoring after surgery.
This study looks at when liver transplant is offered and what outcomes happen in people with cirrhosis who have severe “acute-on-chronic” worsening. It may help doctors decide which patients benefit most from transplant and improve care after listing or not listing.
This study tests a treatment that cleans your blood to help your liver recover if you have sudden liver failure. It may improve your chances of getting better.
This study tests a blood-filtering system called CytoSorb in people with severe liver failure that also affects other organs. It aims to see if removing toxins from the blood can help reduce damage and improve recovery.
Hear when a new Liver Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.